129 related articles for article (PubMed ID: 26024630)
1. Next-Generation Sequencing for Antenatal Prediction of KEL1 Blood Group Status.
Rieneck K; Clausen FB; Dziegiel MH
Methods Mol Biol; 2015; 1310():115-21. PubMed ID: 26024630
[TBL] [Abstract][Full Text] [Related]
2. Next-generation sequencing: proof of concept for antenatal prediction of the fetal Kell blood group phenotype from cell-free fetal DNA in maternal plasma.
Rieneck K; Bak M; Jønson L; Clausen FB; Krog GR; Tommerup N; Nielsen LK; Hedegaard M; Dziegiel MH
Transfusion; 2013 Nov; 53(11 Suppl 2):2892-8. PubMed ID: 23550721
[TBL] [Abstract][Full Text] [Related]
3. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen.
Poole J; Warke N; Hustinx H; Taleghani BM; Martin P; Finning K; Crew VK; Green C; Bromilow I; Daniels G
Transfusion; 2006 Nov; 46(11):1879-85. PubMed ID: 17076841
[TBL] [Abstract][Full Text] [Related]
4. Prenatal diagnosis of Kell blood group genotypes: KEL1 and KEL2.
Lee S; Bennett PR; Overton T; Warwick R; Wu X; Redman CM
Am J Obstet Gynecol; 1996 Aug; 175(2):455-9. PubMed ID: 8765268
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry.
Li Y; Finning K; Daniels G; Hahn S; Zhong X; Holzgreve W
Prenat Diagn; 2008 Mar; 28(3):203-8. PubMed ID: 18241084
[TBL] [Abstract][Full Text] [Related]
6. Genotyping of KEL1 and KEL2 of the human Kell blood group system by the polymerase chain reaction with sequence-specific primers.
Hessner MJ; McFarland JG; Endean DJ
Transfusion; 1996 Jun; 36(6):495-9. PubMed ID: 8669079
[TBL] [Abstract][Full Text] [Related]
7. Prenatal determination of genotypes Kell and Cellano in at-risk pregnancies.
Spence WC; Maddalena A; Demers DB; Bick DP
J Reprod Med; 1997 Jun; 42(6):353-7. PubMed ID: 9219123
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive Antenatal Determination of Fetal Blood Group Using Next-Generation Sequencing.
Rieneck K; Clausen FB; Dziegiel MH
Cold Spring Harb Perspect Med; 2015 Oct; 6(1):a023093. PubMed ID: 26511760
[TBL] [Abstract][Full Text] [Related]
9. A novel KEL*1,3 allele with weak Kell antigen expression confirming the cis-modifier effect of KEL3.
Körmöczi GF; Scharberg EA; Gassner C
Transfusion; 2009 Apr; 49(4):733-9. PubMed ID: 19347978
[TBL] [Abstract][Full Text] [Related]
10. Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma.
Finning K; Martin P; Summers J; Daniels G
Transfusion; 2007 Nov; 47(11):2126-33. PubMed ID: 17958542
[TBL] [Abstract][Full Text] [Related]
11. [Antenatal determination of fetal RhD-blood type based on fetal DNA in plasma from the RhD-negative mother--secondary publication].
Clausen FB; Krog GR; Rieneck K; Nielsen LK; Lundquist R; Finning K; Dickmeiss E; Hedegaard M; Dziegiel MH
Ugeskr Laeger; 2006 Jun; 168(26-32):2568-70. PubMed ID: 16824414
[TBL] [Abstract][Full Text] [Related]
12. Clinical Potential of Effective Noninvasive Exclusion of KEL1-Positive Fetuses in KEL1-Negative Pregnant Women.
Böhmova J; Vodicka R; Lubusky M; Holuskova I; Studnickova M; Kratochvilova R; Krejcirikova E; Janikova M; Durdová V; Dolezalová T; Filipová H; Dusek L; Dhaifalah I; Vomackova K; Kacerovsky M; Prochazka M; Vrtel R
Fetal Diagn Ther; 2016; 40(1):48-53. PubMed ID: 26492079
[TBL] [Abstract][Full Text] [Related]
13. Another example of a KEL1 variant red cell phenotype due to a threonine to serine change at position 193 of Kell glycoprotein.
Lee-Stroka H; Slezak SL; Adams S; Martin J; Robbins FM; Caruccio L; Byrne KM; Stroncek DF
Transfusion; 2008 May; 48(5):925-9. PubMed ID: 18248571
[TBL] [Abstract][Full Text] [Related]
14. Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells.
Smith NH; Henry KL; Cadwell CM; Bennett A; Hendrickson JE; Frame T; Zimring JC
Transfusion; 2012 Dec; 52(12):2620-30. PubMed ID: 22494154
[TBL] [Abstract][Full Text] [Related]
15. Genetic diversity of KELnull and KELel: a nationwide Austrian survey.
Körmöczi GF; Wagner T; Jungbauer C; Vadon M; Ahrens N; Moll W; Mühlbacher A; Ozgül-Gülce S; Kleinrath T; Kilga-Nogler S; Schönitzer D; Gassner C
Transfusion; 2007 Apr; 47(4):703-14. PubMed ID: 17381630
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive diagnostics of fetal KEL*01.01 allele from maternal plasma of immunized women using digital PCR protocols.
Orzińska A; Krzemienowska M; Purchla-Szepioła S; Kopeć I; Guz K
Transfusion; 2022 Apr; 62(4):863-870. PubMed ID: 35191535
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive prenatal diagnostic testing for β-thalassaemia using cell-free fetal DNA and next generation sequencing.
Xiong L; Barrett AN; Hua R; Tan TZ; Ho SS; Chan JK; Zhong M; Choolani M
Prenat Diagn; 2015 Mar; 35(3):258-65. PubMed ID: 25400264
[TBL] [Abstract][Full Text] [Related]
18. [New frontiers in noninvasive, prenatal screening and diagnosis: fetal DNA circulating in maternal blood].
Montagnana M; Lippi G; Guidi GC
Minerva Ginecol; 2007 Jun; 59(3):331-41. PubMed ID: 17576408
[TBL] [Abstract][Full Text] [Related]
19. An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigens.
Cro' F; Lapucci C; Vicari E; Salsi G; Rizzo N; Farina A
Am J Reprod Immunol; 2016 Dec; 76(6):499-503. PubMed ID: 27730708
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive prenatal blood group genotyping.
Doescher A; Müller TH
Methods Mol Biol; 2015; 1310():135-47. PubMed ID: 26024632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
